QuidelOrtho Statistics

Total Valuation

QuidelOrtho has a market cap or net worth of GBP 2.43 billion. The enterprise value is 4.57 billion.

Market Cap	2.43B
Enterprise Value	4.57B

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.26%
Shares Change (QoQ)	+0.30%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	62.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.70, with an EV/FCF ratio of -63.23.

EV / Earnings	-3.28
EV / Sales	2.00
EV / EBITDA	8.70
EV / EBIT	44.09
EV / FCF	-63.23

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.87.

Current Ratio	1.38
Quick Ratio	0.67
Debt / Equity	0.87
Debt / EBITDA	4.30
Debt / FCF	-28.72
Interest Coverage	0.66

Financial Efficiency

Return on equity (ROE) is -45.79% and return on invested capital (ROIC) is 1.17%.

Return on Equity (ROE)	-45.79%
Return on Assets (ROA)	1.04%
Return on Capital (ROIC)	1.17%
Revenue Per Employee	296,156
Profits Per Employee	-196,190
Employee Count	7,100
Asset Turnover	0.37
Inventory Turnover	2.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.87% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.87%
50-Day Moving Average	41.75
200-Day Moving Average	41.32
Relative Strength Index (RSI)	54.33
Average Volume (20 Days)	191

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.36

Income Statement

In the last 12 months, QuidelOrtho had revenue of GBP 2.10 billion and -1.39 billion in losses. Loss per share was -20.78.

Revenue	2.10B
Gross Profit	1.00B
Operating Income	95.22M
Pretax Income	-1.49B
Net Income	-1.39B
EBITDA	437.68M
EBIT	95.22M
Loss Per Share	-20.78

Full Income Statement

Balance Sheet

The company has 108.95 million in cash and 2.07 billion in debt, giving a net cash position of -1.97 billion.

Cash & Cash Equivalents	108.95M
Total Debt	2.07B
Net Cash	-1.97B
Net Cash Per Share	n/a
Equity (Book Value)	2.38B
Book Value Per Share	35.39
Working Capital	287.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 74.40 million and capital expenditures -146.64 million, giving a free cash flow of -72.24 million.

Operating Cash Flow	74.40M
Capital Expenditures	-146.64M
Free Cash Flow	-72.24M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 47.57%, with operating and profit margins of 4.53% and -66.25%.

Gross Margin	47.57%
Operating Margin	4.53%
Pretax Margin	-70.97%
Profit Margin	-66.25%
EBITDA Margin	20.81%
EBIT Margin	4.53%
FCF Margin	n/a

Dividends & Yields

QuidelOrtho does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.26%
Shareholder Yield	-0.26%
Earnings Yield	-57.35%
FCF Yield	-2.97%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

QuidelOrtho has an Altman Z-Score of 1.18. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.18
Piotroski F-Score	n/a